Markets:

Overview

News

Currencies

International

Treasuries

Viatris Inc. - Common Stock (NQ:VTRS)

14.88 -0.05 (-0.37%)

Streaming Delayed Price Updated: 10:46 AM EST, Mar 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viatris Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

21 22 Next >

Bastion Bets on Government Spending with $8 Million New Stake in Parsons ↗

February 27, 2026

Parsons delivers technology-driven solutions for defense, intelligence, and critical infrastructure clients across North America and beyond.

Via The Motley Fool

The Pivot to Growth: Viatris (VTRS) Enters Phase 2 with 2026 Dividend and Capital Allocation Strategy

February 26, 2026

As of February 26, 2026, Viatris Inc. (NASDAQ: VTRS) finds itself at a defining crossroads. For years, the company was viewed by many on Wall Street as a "value trap"—a debt-laden giant formed from the...

Via Finterra

Topics Economy

Wondering what's happening in today's S&P500 pre-market session? ↗

February 26, 2026

Via Chartmill

Viatris Inc (NASDAQ:VTRS) Beats Q4 2025 Estimates and Completes Strategic Review ↗

February 26, 2026

Via Chartmill

Viatris (NASDAQ:VTRS) Posts Better-Than-Expected Sales In Q4 CY2025

February 26, 2026

Medication company Viatris (NASDAQ:VTRS) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 5% year on year to $3.7 billion. The company’s full-year revenue guidance of...

Via StockStory

Earnings To Watch: Viatris (VTRS) Reports Q4 Results Tomorrow

February 24, 2026

Medication company Viatris (NASDAQ:VTRS) will be announcing earnings results this Thursday before market hours. Here’s what to expect.

Via StockStory

Topics World Trade

Supreme Court Strikes Down IEEPA Tariffs, Mandating Billions in Immediate Rebates

February 24, 2026

In a seismic shift for global trade and constitutional law, the Supreme Court of the United States ruled on February 20, 2026, that the executive branch lacks the authority to unilaterally impose...

Via MarketMinute

Topics Bonds Economy Government

February 22, 2026

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...

Via StockStory

2 Value Stocks Worth Your Attention and 1 We Brush Off

February 16, 2026

Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful...

Via StockStory

Viatris at a Crossroads: Transitioning from Generic Giant to Specialty Powerhouse

February 10, 2026

February 10, 2026 Introduction As of February 2026, Viatris Inc. (NASDAQ: VTRS) finds itself at a pivotal juncture. Five years after its high-profile inception, the company has shed its skin as a...

Via Finterra

Topics Economy World Trade

Why Viatris (VTRS) Stock Is Up Today

February 09, 2026

Shares of medication company Viatris (NASDAQ:VTRS) jumped 6.4% in the afternoon session after investment bank UBS upgraded the company's stock from "Neutral" to "Buy" and increased its price target.

Via StockStory

Uncover the latest developments among S&P500 stocks in today's session. ↗

February 09, 2026

Via Chartmill

Monday's pre-market session: top gainers and losers in the S&P500 index ↗

February 09, 2026

Via Chartmill

3 Unprofitable Stocks with Questionable Fundamentals

February 03, 2026

Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.

Via StockStory

Topics Electric Vehicles

3 Reasons to Sell VTRS and 1 Stock to Buy Instead

January 21, 2026

What a time it’s been for Viatris. In the past six months alone, the company’s stock price has increased by a massive 41.5%, reaching $13.07 per share. This was partly due to its solid quarterly...

Via StockStory

3 Cash-Producing Stocks with Questionable Fundamentals

January 15, 2026

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

Via StockStory

What's going on in today's session: S&P500 movers ↗

January 15, 2026

Via Chartmill

Thursday's session: gap up and gap down stock in the S&P500 index ↗

January 15, 2026

Via Chartmill

3 Volatile Stocks We Keep Off Our Radar

January 14, 2026

A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared.

Via StockStory

Viatris Inc. (NASDAQ: VTRS): Navigating the Pivot from Integration to Innovation

January 14, 2026

Date: January 14, 2026 Viatris Inc. (NASDAQ: VTRS) stands at a critical crossroads in early 2026. After years of functioning as a complex, debt-laden conglomerate formed from the massive merger of...

Via Finterra

Topics Earnings Economy Intellectual Property

These S&P500 stocks are moving in today's session ↗

January 13, 2026

Via Chartmill

1 Stock Under $50 Worth Your Attention and 2 That Underwhelm

January 07, 2026

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some...

Via StockStory

1 Healthcare Stock to Target This Week and 2 We Turn Down

January 05, 2026

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 17.2% over...

Via StockStory

Topics Stocks

1 Momentum Stock to Target This Week and 2 That Underwhelm

December 31, 2025

The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant...

Via StockStory

Delek Shares Surge 60% but One Fund Walked Away From a $15 Million Position ↗

December 31, 2025

The exit comes after a huge run for the stock, but there's more to it than timing alone.

Via The Motley Fool

Topics Energy

Why One Fund Made a $19 Million Bet on Four Corners Property Trust Even as Shares Fell 15% ↗

December 29, 2025

This quiet REIT move looks less like bargain hunting and more like a calculated play on cash flow durability.

Via The Motley Fool

Topics Regulatory Compliance

Prescription for Growth: Why Zoetis and Viatris are Defining Healthcare’s New Winners in 2025

December 24, 2025

As the curtain closes on 2025, the healthcare sector has emerged as a landscape of stark contrasts. While traditional pharmaceutical giants have grappled with the implementation of the Medicare Part D...

Via MarketMinute

Topics Bonds Earnings World Trade

Exploring the top movers within the S&P500 index during today's session. ↗

December 24, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.

Via Chartmill

1 S&P 500 Stock with Impressive Fundamentals and 2 That Underwhelm

December 18, 2025

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...

Via StockStory

Topics Stocks

Global Prescription Drug Market Poised for Trillion-Dollar Surge by 2035

December 03, 2025

The global prescription drugs market is on the cusp of a significant expansion, with recent market reviews and forecasts projecting a robust growth trajectory through 2035. This anticipated surge,...

Via MarketMinute

Topics Artificial Intelligence Death Intellectual Property

< Previous 1 2 3 4 5 6 7 8 9

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.